Articles tagged with Myocardial Infarction
The FDA has added 'black box' warnings to all prescription and over-the-counter pain relievers, despite evidence showing naproxen is safe. This decision ignores the risk differences between nonsteroidal anti-inflammatory drugs, with Voltaren carrying the highest risk of heart attack.
Researchers found HIV-infected patients had a higher incidence of heart attacks and major cardiovascular risk factors compared to noninfected patients. The study's findings indicate that HIV-infected individuals should be assessed for cardiovascular risks and that strategies to modify those risks are urgently needed.
A study published in JAMA found that ranolazine is safe but ineffective in reducing major cardiovascular events, such as death or heart attack, in patients with acute coronary syndromes. The medication showed a reduced risk of recurrent ischemia, but failed to improve overall cardiovascular outcomes.
Migraines in men are associated with a higher risk of cardiovascular disease and heart attacks. The study found that men who experienced migraines had an increased risk of myocardial infarctions, with an incidence rate of 10.4 per 10,000 men per year.
Research shows that elderly patients (90+ years) who receive recommended treatments for acute coronary syndromes have better survival rates, but at a higher risk of bleeding complications. Guidelines must be balanced to balance survival benefits with increased bleeding risk.
Researchers at Mount Sinai School of Medicine have developed a new imaging technology using multi-detector computed tomography (CT) and a novel contrast agent N1177 to detect high-risk plaque. This may help physicians diagnose a heart attack before it occurs, preventing cardiac events.
A new study found that doctors are treating patients with early symptoms of a heart attack with the same level of urgency as those with later-confirmed cases. This suggests that doctors are using alternative data sources, such as patient history and electrocardiogram results, to make treatment decisions.
A study of 119 Iowa hospitals found that rural hospitals do not have higher death rates for heart attack care, contrary to previous research. The study used a more sensitive analytic method to control for biases and found comparable patient outcomes.
Research found ibuprofen may boost the likelihood of heart problems in high-risk patients with osteoarthritis. High-dose ibuprofen was linked to a higher risk of heart attacks and strokes compared to other treatments, including lumiracoxib and naproxen.
A study assessed whether adding succinobucol, a novel agent with antioxidant and anti-inflammatory properties, to optimal medical therapy reduces coronary events and death. The trial achieved a 19% relative risk reduction in hard atherosclerotic clinical endpoints, including cardiovascular death, myocardial infarction, and stroke.
The COURAGE trial found that PCI reduces neither mortality nor heart attack in patients with chronic stable angina when added to optimal drug therapy. SCAI leaders emphasize the importance of discussing treatment options and goals with patients, as therapy may not be suitable for every patient.
A new five-year study published in the New England Journal of Medicine found that stable heart patients received no significant benefit from undergoing angioplasty compared to those treated with medication alone. The study showed a 19.5% rate of death, heart attack, and stroke among medication-only patients versus 20% for PCI recipients.
A study published in the Journal of Neuroscience found that multiple regions of the brain are involved in determining pain location, contradicting conventional wisdom. The research used functional magnetic resonance imaging (MRI) to identify areas of brain activity while participants evaluated the spatial location of a thermal stimulus.
A Phase I study at Rush University Medical Center found that adult stem cell therapy significantly improved heart, lung, and global function in heart attack patients. Patients receiving the therapy experienced a lower number of adverse events and were 75% less likely to experience arrhythmic events compared to those receiving a placebo.
A study published in the New England Journal of Medicine found that pairing percutaneous coronary interventions (PCI) with optimal medical therapy (OMT) is no more effective than OMT alone in preventing heart attacks and other cardiac events. The study showed similar rates of death, heart attack, or stroke between patients who received...
A new thrombin-receptor antagonist (TRA) has shown significant reduction in serious cardiovascular events, mainly heart attacks, with no increase in bleeding risks in a high-risk patient population. The study found a 46% lowering in serious cardiovascular events, an early and strong efficacy signal for this novel antiplatelet compound.
Researchers studied the outcomes of treating ST- elevation myocardial infarction with PCI alone or with distal protection, finding similar major adverse cardiac events and electrocardiographic results. However, post-procedure blood flow was improved in patients treated with distal protection.
The study found that Crestor arrested the progression of thickened carotid arteries in participants with moderately elevated cholesterol levels. The therapy also lowered low-density lipoprotein and increased high-density lipoprotein, as well as reduced triglycerides.
A Phase 1 study evaluating a novel protein kinase C inhibitor, KAI-9803, suggests potential benefit in healing time and tissue function for heart attack patients. The trial showed improved tissue perfusion and reduced infarct size at lower dose levels.
A study comparing drug-eluting stents (DES) and bare-metal stents (BMS) found similar rates of complications, including stent thrombosis, MI, and mortality. However, DES patients had a slightly increased risk of stent thrombosis and heart attack between 12-15 months after implantation.
A large study found that patients with established arterial disease have significantly higher cardiovascular event rates than those with multiple risk factors only. The rates increased directly with the number of symptomatic arterial disease locations, emphasizing the need for improved secondary prevention and clinical outcomes.
A national study will enroll 1,124 participants to investigate implanting a pacemaker in low-heart rate, heart-attack patients to improve survival rates and determine the frequency of low heart rates in these patients. The five-year study aims to explore the effectiveness of beta-blocker therapy for this specific patient group.
A new clinical trial has shown that intensive treatment for periodontitis, a common inflammatory gum disease, can improve blood vessel function and reduce the risk of heart attacks and strokes. The study suggests that treating gum disease could be an important step in preventing cardiovascular disease.
Researchers found that erectile dysfunction drugs like Viagra and Levitra can reduce heart damage after a heart attack, while nitroglycerin failed to offer similar protection. The study suggests these drugs may have potential as adjunct therapy for patients undergoing high-risk procedures or experiencing cardiac arrest.
A study of 24 couples found that nine reported positive changes in their lives after the experience, including increased closeness and practical adjustments. Meanwhile, ten couples felt fearful and threatened by the uncertainty of their partner's health, while five others failed to make meaningful changes.
Adding CRP testing to routine assessments would increase Americans eligible for treatment by 2-25 million, mostly low-risk individuals. The medical community should focus on treating high-risk patients before expanding to low-risk populations.
Researchers found that a core clock gene regulates stress response and blood pressure, providing a novel link to the diurnal variation in heart attack risk. The study suggests modifying the molecular clock using drugs could be a treatment for people with high blood pressure.
A study analyzing Hodgkin disease treatment found that patients are at increased risk of fatal heart attacks for at least 25 years after treatment. Cardiovascular disease is the second leading cause of death in long-term survivors, with myocardial infarction being the most common cause.
The Society for Cardiovascular Angiography and Interventions recommends stringent quality standards for PCI in hospitals without on-site cardiac surgery. These standards aim to ensure patient safety and excellent clinical outcomes, including case volume limits and training of support personnel.
Researchers at Thomas Jefferson University Hospital report a case of a seemingly healthy man who suffered from unexplained chest pain after a silent heart attack. The team discovered a subepicardial aneurysm, a rarely diagnosed complication that can be fatal if left untreated.
A long-term study found that men with hypertension who consumed one to two drinks a day had a decreased risk of fatal and non-fatal heart attacks. Rates of stroke and death from heart disease and all causes did not differ for hypertensive men who drank moderately or those who drank no alcohol.
A large-scale study found that immunosuppressive medications in RA patients may increase cardiovascular risk, particularly with cytotoxic agents and glucocorticoids. Biologic therapies, including TNF blockers, showed no protective effect against heart attacks or strokes.
A meta-analysis of seven clinical trials found that statins can reduce the risk of major heart and cerebrovascular events in healthy individuals. However, these medications do not appear to provide significant benefits for those without cardiovascular disease or abnormal cholesterol levels.
Researchers are using computed tomography to study the effects of fat stored around the heart and its potential contribution to atherosclerosis. The study aims to investigate whether fat deposits in the arteries increase the risk of fatty deposits and inflammation, leading to heart attacks.
Research reveals that heart attack-related depression significantly increases the risk of further cardiovascular emergencies. The DepreMI Study found that incident post-heart attack depression is linked to a poor prognosis, warranting more targeted screenings and treatments.
A study published in Nature demonstrated TB4's ability to regenerate coronary vessels in mice, a finding that could lead to new treatments for human heart disease. TB4 may prevent loss of heart muscle cells and restore blood flow, providing a much-needed treatment modality.
A new analysis by Duke University Medical Center cardiologists found that taking low-dose aspirin daily reduces the risk of heart attack, stroke, and death among patients with stable cardiovascular disease. The study also showed an increased risk of bleeding, but the protective benefits of aspirin outweigh this side effect.
A study of over 44,000 patients found that blood transfusions were associated with a benefit in those with low hematocrit levels but harm in others. For patients with moderate hematocrit levels, transfusions showed no benefit or harm, suggesting providers may reconsider their decision-making process.
A large international clinical trial found that stable patients who received late angioplasty after a heart attack did not have better outcomes than those on medical therapy alone. The study suggests that routine late opening of the blocked artery is unnecessary and should be reserved for unstable patients.
A new study published in the New England Journal of Medicine found that patients who undergo angioplasty to open their totally blocked coronary arteries days after a heart attack do not reduce their risk of having another heart attack, going into heart failure, or dying. The study, which involved over 2,166 patients on five continents,...
Researchers at Yale School of Medicine found that hospitals using six specific strategies have faster door-to-balloon times, resulting in better patient outcomes. These strategies include activating the catheterization laboratory and having real-time data feedback for staff.
Researchers at Johns Hopkins Medicine have successfully grown and implanted adult pig stem cells to repair damaged heart tissue after a lab-induced heart attack. The study demonstrates proof of principle for using cardiac stem cell therapy to regenerate infarcted heart muscle and restore heart cell function.
Researchers found that TSA and SAHA decreased cholesterol deposits and prevented macrophages from forming foam cells inside arterial walls. These findings suggest the potential for these anti-inflammatory drugs to stabilize atherosclerotic plaque and reduce acute coronary events.
A study by Mayo Clinic researchers has found that people with psoriasis are more likely to develop heart disease, including heart attacks and heart failure. The study, which followed 622 adults with psoriasis and a control group of 622 people, found significant increases in cardiovascular events among those with psoriasis.
A new study published in Archives of Internal Medicine found that moderate drinking reduces men's heart attack risk. Among men with healthy lifestyles, those who consumed moderate amounts of alcohol had a 40-60 percent reduced risk of heart attack compared to non-drinkers and very light drinkers.
A recent study found that moderate drinking may be associated with a reduced risk of heart attack in healthy men. The research, conducted on 8,867 healthy men, suggests that even light drinkers have a lower risk than those who do not drink at all. Moderate drinking was linked to increased levels of HDL or 'good' cholesterol in the blood.
A study published in JAMA Network found that adults with psoriasis, particularly those with severe forms of the condition, are at a higher risk for heart attacks. The research also revealed that younger patients with severe psoriasis have a significantly increased relative risk compared to other major cardiac risk factors.
A study published in JAMA found that psoriasis patients are at a higher risk of heart attack, particularly those with severe psoriasis. Younger patients with severe psoriasis had the highest relative risk of heart attack, similar to other major cardiac risk factors.
Researchers at Boston Children's Hospital developed a two-drug treatment that rescues heart function after a heart attack by promoting blood vessel growth and cell division. The study shows improved heart function and reduced scarring in rats treated with the combination of agents.
Researchers discovered a biochemical signaling pathway between blood platelets and monocytes that triggers production of Cox-2, an enzyme involved in heart attack, stroke, and other inflammatory diseases. This finding offers hope for developing new drugs to modify Cox-2 production and prevent or lessen the severity of these conditions.
A team of researchers reviews existing research on LDL cholesterol and heart health, concluding that there is no valid evidence to support ultra-low LDL targets. They suggest focusing on statin therapy for high-risk patients regardless of their cholesterol levels.
Rural India sees a shift from infectious to chronic diseases as the leading cause of death. Cardiovascular disease and injuries now account for over 50% of deaths in rural areas.
A large prospective cohort study found that extremely high levels of lipoprotein(a) in women are associated with an increased risk for cardiovascular events, particularly those with high LDL-C levels. The study included over 27,000 initially healthy women and followed them for 10 years.
ACTOS demonstrated significant improvements in reducing the risk of heart attacks, strokes, and cardiovascular death in high-risk patients with type 2 diabetes. The study showed a 23% reduction in heart attacks and an 18% reduction in combined risk of cardiovascular death, nonfatal heart attack, or nonfatal stroke.
A study of over 17,000 heart attack patients found that only 45% regularly took beta blockers during the first year after discharge, highlighting the need for improved adherence strategies. Factors such as age and insurance status may influence medication adherence, suggesting a broader approach to addressing this issue.
A study of over 68,000 patients in 44 countries found that Eastern Europeans and Middle Easterners have the highest rates of heart attacks, strokes, and deaths from these conditions. The analysis suggests that cardiovascular disease is no longer exclusive to Western, industrialized world.
A recent study published in The Lancet found that all forms of tobacco exposure, including smoking, chewing, and second-hand smoke, increase the risk of heart attack. The study, which included data from over 27,000 people in 52 countries, showed that even low levels of tobacco exposure can double the risk of a heart attack.
A global study found that all forms of tobacco exposure, including second-hand smoke, increase the risk of heart attack. Quitting smoking can significantly reduce this risk, with light smokers benefiting the most.
Researchers at Wake Forest University discovered that fibrin fibers can be stretched up to four times their length before breaking, making them the most stretchable natural fibers known. This discovery has significant implications for understanding blood clot properties and developing new treatments for heart attacks and strokes.
A University of Pittsburgh School of Medicine study found that gout is an independent risk factor for myocardial infarction (heart attack) in men with no previous history of coronary artery disease. Gouty arthritis was associated with modest elevations in blood pressure, age, and body mass index.